Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations(4 sites)
United States
Lurie Children's Hospital, Chicago, Illinois Boston Children's Hospital, Boston, Massachusetts Oregon Health & Science University, Portland, Oregon Canada
The Hospital for Sick Children, Toronto, Ontario